Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chin

Showing results (801-810 of 813) with videos related to

Pageof 82
Sort By:
Frontiers in Cardiovascular Medicine|December 3, 2021
Echocardiographic Global Longitudinal Strain Is Associated With Myocardial Fibrosis and Predicts Outcomes in Aortic StenosisThu-Thao Le, Weiting Huang, Gurpreet K Singh, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 26, 2023
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional surveySteven M Yip, Christopher Morash, Michael P Kolinsky, et al.
Journal of the American College of Cardiology|August 6, 2021
Markers of Myocardial Damage Predict Mortality in Patients With Aortic StenosisSoongu Kwak, Russell J Everett, Thomas A Treibel, et al.
Nature Genetics|November 22, 2016
Titin-truncating variants affect heart function in disease cohorts and the general populationSebastian Schafer, Antonio de Marvao, Eleonora Adami, et al.
Science Advances|July 10, 2026
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
JAMA Cardiology|April 15, 2026
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical TrialNeil J Craig, Krithika Loganath, Russell J Everett, et al.
JAMA Cardiology|February 19, 2025
Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic StenosisSoongu Kwak, Anvesha Singh, Russell J Everett, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
JAMA|October 28, 2024
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical TrialKrithika Loganath, Neil J Craig, Russell J Everett, et al.
Pageof 82

Showing results (801-810 of 813) with videos related to

Sort By:
Pageof 82
Frontiers in Cardiovascular Medicine|December 3, 2021
Echocardiographic Global Longitudinal Strain Is Associated With Myocardial Fibrosis and Predicts Outcomes in Aortic StenosisThu-Thao Le, Weiting Huang, Gurpreet K Singh, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 26, 2023
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional surveySteven M Yip, Christopher Morash, Michael P Kolinsky, et al.
Journal of the American College of Cardiology|August 6, 2021
Markers of Myocardial Damage Predict Mortality in Patients With Aortic StenosisSoongu Kwak, Russell J Everett, Thomas A Treibel, et al.
Nature Genetics|November 22, 2016
Titin-truncating variants affect heart function in disease cohorts and the general populationSebastian Schafer, Antonio de Marvao, Eleonora Adami, et al.
Science Advances|July 10, 2026
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
JAMA Cardiology|April 15, 2026
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical TrialNeil J Craig, Krithika Loganath, Russell J Everett, et al.
JAMA Cardiology|February 19, 2025
Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic StenosisSoongu Kwak, Anvesha Singh, Russell J Everett, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
JAMA|October 28, 2024
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical TrialKrithika Loganath, Neil J Craig, Russell J Everett, et al.
Pageof 82